π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a randomized, double-blind, active drug- and placebo-controlled, do...
Status
Recruiting
Location
The Third Xiangya Hospital of Central South University
Start Date
2026-03-30
Trial ID
NCT07519109
Treatments Being Tested
The study is an open-label Phase 1 single dose-escalation safety study of C...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2018-10-15
Trial ID
NCT03464916
Treatments Being Tested
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
Considerable progress in the treatment of metastatic melanoma has been made...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-10
Trial ID
NCT02619058
Treatments Being Tested
This trial is divided into two parts, a dose-escalation study (phase 1) and...
Status
Suspended
Location
University of Alabama at Birmingham
Start Date
2013-08
Trial ID
NCT01933815
Treatments Being Tested
This randomized, double-blind, placebo-controlled, single ascending dose st...
Status
Completed
Location
Changi General Hospital; Clinical Trial & Research unit
Start Date
2013-12
Trial ID
NCT02015715
To evaluate the safety and tolerability of single dose of SYH2082 Injection...
Status
Active Not Recruiting
Location
The Affiliated Hospital of Nanjing University Medical School
Start Date
2026-04-13
Trial ID
NCT07736404
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and pharm...
Status
Completed
Location
Site US0006
Start Date
2014-10-14
Trial ID
NCT02175433
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and prel...
Status
Active Not Recruiting
Location
University of Alabama At Birmingham
Start Date
2021-02-23
Trial ID
NCT04279847
Treatments Being Tested
Evaluate the safety and tolerability of VX-659 in healthy subjects...
Status
Completed
Location
Multiple Locations
Start Date
2016-11
Trial ID
NCT03029455
Treatments Being Tested